281 filings
15-12G
Innovus Pharmaceuticals, Inc.
26 Feb 20
Securities registration termination
12:00am
S-8 POS
Innovus Pharmaceuticals, Inc.
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:23pm
S-8 POS
Innovus Pharmaceuticals, Inc.
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:22pm
S-8 POS
Innovus Pharmaceuticals, Inc.
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:21pm
S-8 POS
Innovus Pharmaceuticals, Inc.
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:20pm
S-8 POS
4howex9e
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:19pm
S-8 POS
cwqjtfluozg 0x
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:19pm
S-8 POS
atowuhyd cbm22nznn6
25 Feb 20
Registration of securities for employees (post-effective amendment)
2:18pm
8-K
h0rgsm7407ix
14 Feb 20
Submission of Matters to a Vote of Security Holders
6:03am
8-K
o1hx qeds
14 Feb 20
Completion of Acquisition or Disposition of Assets
12:00am
425
eap724p3qfmud939z
3 Oct 19
Business combination disclosure
5:05pm
425
eqs u9xefywoju916dgl
23 Sep 19
Business combination disclosure
6:33am
8-K
8w7y6ino2o 1jm
18 Sep 19
Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals
5:18pm
425
7so8q3sc 3rwamllk3
18 Sep 19
Business combination disclosure
5:16pm
425
pddin
13 Sep 19
Business combination disclosure
2:00pm
8-K
udbedu jfrugnnran
13 Aug 19
Innovus Pharma Reports Quarterly Revenue for the Second Quarter 2019 of $6.8 million, a 27.7% Increase from Prior Quarter
4:01pm
8-K
f98 co8hyx
24 Jul 19
Departure of Directors or Certain Officers
9:30am
8-K
gli2nksqqzc9kwq
22 Jul 19
Other Events
6:03am